Bevacizumab for Metastatic Colorectal Cancer: A NICE Single Technology Appraisal

Author： Whyte Sophie   Pandor Abdullah   Stevenson Matt  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.12, 2012-12, pp. : 1119-1132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal

By Bagust Adrian  

PharmacoEconomics, Vol. 28, Iss. 6, 2010-06 ,pp. : 439-448

Adis International

Access to resources Recommend Favorite

Bevacizumab: A Review of its Use in Metastatic Colorectal Cancer

By McCormack Paul L.   Keam Susan J.  

Drugs, Vol. 68, Iss. 4, 2008-01 ,pp. : 487-506

Adis International

Access to resources Recommend Favorite

Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal

By McKenna Claire  

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 35-46

Adis International

Access to resources Recommend Favorite

Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal

By Rodgers Mark  

PharmacoEconomics, Vol. 28, Iss. 5, 2010-05 ,pp. : 351-362

Adis International

Access to resources Recommend Favorite

Golimumab for the Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal

By Yang Huiqin  

PharmacoEconomics, Vol. 30, Iss. 4, 2012-04 ,pp. : 257-270

Adis International

Access to resources Recommend Favorite